PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WELL Health Technologies Corp. (WELL.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCA94947L1022
CUSIP94947L102
SectorHealthcare
IndustryMedical Care Facilities

Highlights

Market CapCA$1.27B
EPS (TTM)CA$0.31
PE Ratio16.52
Total Revenue (TTM)CA$705.96M
Gross Profit (TTM)CA$276.58M
EBITDA (TTM)CA$82.21M
Year RangeCA$3.41 - CA$5.38
Target PriceCA$7.63
Short %1.84%
Short Ratio2.13

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: WELL.TO vs. GWO.TO, WELL.TO vs. USPH, WELL.TO vs. BGFV, WELL.TO vs. CTS, WELL.TO vs. QQQ, WELL.TO vs. RY.TO

Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in WELL Health Technologies Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
35.25%
16.03%
WELL.TO (WELL Health Technologies Corp.)
Benchmark (^GSPC)

Returns By Period

WELL Health Technologies Corp. had a return of 34.55% year-to-date (YTD) and 19.35% in the last 12 months. Over the past 10 years, WELL Health Technologies Corp. had an annualized return of 59.40%, outperforming the S&P 500 benchmark which had an annualized return of 11.39%.


PeriodReturnBenchmark
Year-To-Date34.55%25.48%
1 month14.35%2.14%
6 months35.25%12.76%
1 year19.35%33.14%
5 years (annualized)30.48%13.96%
10 years (annualized)59.40%11.39%

Monthly Returns

The table below presents the monthly returns of WELL.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.52%6.79%-10.27%-0.54%2.74%25.60%2.76%-7.02%-1.56%0.00%34.55%
202326.06%25.70%8.00%14.40%-12.59%-2.26%-0.63%0.00%-12.08%-10.84%2.70%1.32%35.56%
2022-6.92%-0.88%15.01%-13.63%-13.78%-20.88%13.03%1.73%-12.75%-5.19%3.42%-5.96%-42.16%
2021-6.83%18.40%-19.14%0.56%-0.55%22.28%-16.51%9.00%-11.39%-7.06%-13.37%-13.86%-39.01%
202017.31%-8.74%-10.18%40.00%35.71%0.35%30.07%29.84%49.28%1.94%-4.35%14.51%416.03%
2019-4.44%20.93%28.85%-1.49%13.64%22.67%76.09%0.62%-5.52%-9.09%-0.71%12.23%246.67%
2018-3.41%-28.24%-18.03%192.00%-27.40%-28.30%23.68%19.15%-7.14%-13.46%-3.33%3.45%2.27%
20170.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.45%33.33%40.00%57.14%203.45%
20160.00%0.00%0.00%500.00%0.00%25.00%0.00%-16.67%0.00%-16.00%38.10%0.00%625.00%
20150.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
20140.00%-77.27%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-30.00%-42.86%-90.91%
20133.57%-24.14%0.00%127.27%-12.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%57.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of WELL.TO is 54, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of WELL.TO is 5454
Combined Rank
The Sharpe Ratio Rank of WELL.TO is 5555Sharpe Ratio Rank
The Sortino Ratio Rank of WELL.TO is 5151Sortino Ratio Rank
The Omega Ratio Rank of WELL.TO is 5151Omega Ratio Rank
The Calmar Ratio Rank of WELL.TO is 5454Calmar Ratio Rank
The Martin Ratio Rank of WELL.TO is 5959Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for WELL Health Technologies Corp. (WELL.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


WELL.TO
Sharpe ratio
The chart of Sharpe ratio for WELL.TO, currently valued at 0.45, compared to the broader market-4.00-2.000.002.004.000.45
Sortino ratio
The chart of Sortino ratio for WELL.TO, currently valued at 0.95, compared to the broader market-4.00-2.000.002.004.006.000.95
Omega ratio
The chart of Omega ratio for WELL.TO, currently valued at 1.13, compared to the broader market0.501.001.502.001.13
Calmar ratio
The chart of Calmar ratio for WELL.TO, currently valued at 0.32, compared to the broader market0.002.004.006.000.32
Martin ratio
The chart of Martin ratio for WELL.TO, currently valued at 1.82, compared to the broader market0.0010.0020.0030.001.82
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.91, compared to the broader market-4.00-2.000.002.004.002.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.88, compared to the broader market-4.00-2.000.002.004.006.003.88
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.501.001.502.001.55
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 4.20, compared to the broader market0.002.004.006.004.20
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 18.80, compared to the broader market0.0010.0020.0030.0018.80

Sharpe Ratio

The current WELL Health Technologies Corp. Sharpe ratio is 0.45. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of WELL Health Technologies Corp. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
0.45
3.29
WELL.TO (WELL Health Technologies Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


WELL Health Technologies Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-43.88%
0
WELL.TO (WELL Health Technologies Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the WELL Health Technologies Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the WELL Health Technologies Corp. was 98.33%, occurring on Dec 9, 2014. Recovery took 748 trading sessions.

The current WELL Health Technologies Corp. drawdown is 43.88%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.33%Apr 23, 2013411Dec 9, 2014748Dec 1, 20171159
-71.51%Feb 25, 2021460Dec 22, 2022
-50%May 1, 2018156Dec 11, 2018117May 31, 2019273
-47.92%Dec 21, 201766Mar 28, 201819Apr 25, 201885
-46.67%Mar 26, 20136Apr 3, 20137Apr 12, 201313

Volatility

Volatility Chart

The current WELL Health Technologies Corp. volatility is 15.82%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%JuneJulyAugustSeptemberOctoberNovember
15.82%
4.13%
WELL.TO (WELL Health Technologies Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of WELL Health Technologies Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for WELL Health Technologies Corp..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items